Resultados de la búsqueda 61-70 of 12080 for Neurofibromatosis type 2
... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme ...
... neurofibromatosis type 1 (NF1). Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma.
It is not yet known whether selumetinib works better in treating patients with NF1-associated low-grade glioma compared to standard therapy with carboplatin and ...
They can show whether the tumor is at high risk of being a cancer, which is rare. Imaging tests might include: CT scan. This type of scan takes a series of X- ...
The purpose of phase 2 of this trial is to ... A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade ...
... NF2 mutated meningiomas who have either NF2 disease-related meningioma or sporadic meningiomas that have NF2 mutations. A Study of Navicixizumab Monotherapy ...
Prueba de hemoglobina glucosilada (A1c). Esta prueba indica el nivel promedio de glucosa sanguínea de tu hijo durante los últimos 3 meses. Un nivel de ...
Part 2 of the study will prospectively evaluate the urine concentrations of mast cell mediators in a cohort of pediatric allergic disorder patients including ...
... neurofibromatosis type 1 (NF1). A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?